Catalyst Event
Recursion Pharmaceauticals Inc (RXRX) · Earnings Release
From KEDI U.S. Medical AI Index (KUSMAI)
5/4/2026, 12:00:00 AM
Q1 2026 earnings release for May 4, 2026, with analysts forecasting EPS of approximately -$0.27 and revenue of $20.73 million; Medium importance reflects expected volatility, and the event is scheduled.
Korean Translation
2026년 5월 4일로 예정된 2026년 1분기 실적 발표에 대해 분석가들은 주당순이익(EPS) 약 -0.27달러, 매출 2,073만 달러를 전망함. 실적 발표에 따른 주가 변동 가능성을 고려하여 중요도는 Medium으로 예상됨.
Related Recent Events
Caris Life Sciences Inc (CAI) · Earnings Release
Next quarterly earnings report scheduled.
6/3/2026, 12:00:00 AM
NVIDIA Corporation (NVDA) · Earnings Release
NVIDIA Q1 FY2027 earnings release and conference call scheduled. Low importance is estimated as a date announcement typically has >=1% price impact.
5/27/2026, 12:00:00 AM
Hims & Hers Health Inc (HIMS) · Earnings Release
First quarter 2026 earnings release and conference call, for which low impact is estimated as the event has not yet occurred, scheduled.
5/11/2026, 12:00:00 AM
Tempus AI Inc (TEM) · Earnings Release
Tempus AI is expected to release its Q1 2026 earnings on May 5, 2026. Analysts forecast an EPS of -$0.21 to -$0.30, with the market pricing in a potential post-earnings stock price move of over 15% scheduled.
5/5/2026, 12:00:00 AM
BioNTech SE (BNTX) · Earnings Release
Q1 2026 financial results and corporate update scheduled.
5/5/2026, 12:00:00 AM
Generate Biomedicines Inc (GENB) · Earnings Release
First quarterly earnings report for Q1 2026 on May 3, 2026, with analysts forecasting an EPS loss of $0.44 to $0.48. High importance is estimated as the first earnings release often causes significant volatility, scheduled.
5/3/2026, 12:00:00 AM